Ads
    Related paper
  1. EFFECT OF VARIOUS SUPERDISINTEGRANTS ON IMMEDIATE RELEASE FORMULATIONS OF SGLT2 INHIBITOR DAPAGLIFLOZIN
  2. Effect of Various Superdisintegrants on Immediate Release Formulations of SGLT2 Inhibitor Canagliflozin
  3. Extended Release Topiramate Formulations in Epilepsy
  4. ‘Antiedemigeno Dog-Cat Slow Release’: A Potent In Vitro Inhibitor of LPS Activity |Biomedgrid
  5. PHARMACOKINETIC EVALUATION OF PLGA & PLA BASED LONG ACTING RELEASE (LAR) MICROSPHERE FORMULATIONS OF CETRORELIX IN RATS
  6. FORMULATION DESIGN AND OPTIMIZATION OF FAST DISINTEGRATING TABLETS OF VALSARTAN: EFFECT OF SUPERDISINTEGRANTS
  7. Comparative Study on Effect of Natural and Synthetic Superdisintegrants in the Formulation of Metoclopramide HCL Mouth Dissolving Tablets
  8. APPLICATION OF MODEL INDEPENDENT APPROACH ON IN VITRO RELEASE OF EXTEMPORANEOUSLY PREPARED SEMISOLID FORMULATIONS CONTAINING METRONIDAZOLE WITH MARKETED SILVER SULFADIAZINE 1% CREAM, USP: A COMPARATIVE INVESTIGATION
  9. EFFECT OF SODIUM–GLUCOSE CO-TRANSPORT-2 (SGLT-2) INHIBITORS ON INTRA ORAL WOUND HEALING IN ALBINO RATS, AN EXPERIMENTAL STUDY
  10. Nephroprotective effect of dapagliflozin in type 2 diabetes mellitus: A potential role of Klotho protein